Literature DB >> 26126168

Haemophilia A and B as a cause for secondary osteoporosis and increased fracture risk.

Panagiotis Anagnostis1, Spyridon Karras, Stavroula A Paschou, Dimitrios G Goulis.   

Abstract

Despite the increasing evidence regarding its association with low bone mineral density (BMD) both in adults and children, haemophilia A or B has not yet been considered among the classic causes of secondary osteoporosis. Although the exact mechanisms are not fully elucidated, physical inactivity and vitamin D deficiency seem to play a fundamental role for such an association. Viral infections and arthropathy further compromise bone mass. Except for low BMD, patients with haemophilia seem to be at increased risk for fracture and falls. The FRAX tool may be of value in this population, for the estimation of fracture risk. Regular exercise, prophylactic factor replacement therapy in severe haemophilia, fall prevention strategies and optimization of calcium and vitamin D intake are recommended. In any case, individualized multidisciplinary approach and careful assessment and management of fracture risk are recommended.

Entities:  

Mesh:

Year:  2015        PMID: 26126168     DOI: 10.1097/MBC.0000000000000330

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  7 in total

1.  Evaluation of bone mineral density and related parameters in patients with haemophilia: a single center cross-sectional study.

Authors:  Hatice Demet Kiper Unal; Melda Comert Ozkan; Fatos Dilan Atilla; Zuhal Demirci; Nur Soyer; Ilgin Yildirim Simsir; Ozgur Omur; Kazim Capaci; Guray Saydam; Fahri Sahin
Journal:  Am J Blood Res       Date:  2017-11-01

Review 2.  Bone quality changes associated with aging and disease: a review.

Authors:  Adele L Boskey; Laurianne Imbert
Journal:  Ann N Y Acad Sci       Date:  2017-12       Impact factor: 5.691

3.  Total knee arthroplasty in patients with haemophilic arthropathy is effective and safe according to the outcomes at a mid-term follow-up.

Authors:  Rui Wang; Zhengming Wang; Yong Gu; Jingjing Zhang; Penghe Wang; Peijian Tong; Shuaijie Lv
Journal:  J Orthop Traumatol       Date:  2022-07-11

4.  Blood-induced bone loss in murine hemophilic arthropathy is prevented by blocking the iRhom2/ADAM17/TNF-α pathway.

Authors:  Coline Haxaire; Narine Hakobyan; Tania Pannellini; Camila Carballo; David McIlwain; Tak W Mak; Scott Rodeo; Suchitra Acharya; Daniel Li; Jackie Szymonifka; Xiangqian Song; Sébastien Monette; Alok Srivastava; Jane E Salmon; Carl P Blobel
Journal:  Blood       Date:  2018-05-18       Impact factor: 22.113

Review 5.  Bone Density Status in Bleeding Disorders: Where Are We and What Needs to Be Done?

Authors:  Hassan Mansouritorghabeh; Zahra Rezaieyazdi
Journal:  J Bone Metab       Date:  2017-11-30

6.  Risk Factors for Amputation in the Surgical Treatment of Hemophilic Osteoarthropathy: A 20-Year Single-Center Report.

Authors:  Yiming Xu; Bin Feng; Wei Zhu; Yingjie Wang; Xisheng Weng
Journal:  Pain Res Manag       Date:  2022-03-28       Impact factor: 3.037

7.  Serum Concentrations of Vitamin D, Calcium, Phosphorus and Trace Minerals in Adults and Children with Haemophilia A: Association with Disease Severity, Quality of Life, Joint Health and Functional Status.

Authors:  Amir Abbasnezhad; Mehdi Habibi; Babak Abdolkarimi; Soodabeh Zare; Ezatollah Fazeli Moghadam; Razieh Choghakhori
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2020-01-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.